ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

Capitol Hill: Groups Warn Of Harm From Bill To Promote Breast Self-Exams

May 29, 2009

The Duke Scandal: NEJM Retracts Potti Paper

March 4, 2011

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012